A novel tumor necrosis factor-α suppressant, ONO-SM362, prevents liver failure and promotes liver regeneration after extensive hepatectomy

Surgery

Volumn 143, Issue 4, 2008, Pages 545-555

  Ogata, Toshiro ^a   Yamashita, Kenichiro ^b   Horiuchi, Hiroyuki ^a   Okuda, Koji ^a   Todo, Satoru ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Lab of Molec and Cell Pathology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; 2 HEXYLOXY CARBONYLAMINO 1 METHYL 2 (3 METHOXY PHENYL) ETHYL DISODIUM PHOSPHATE; AMMONIA; CYCLINE; MESSENGER RNA; ONO SM362; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MECHANISM; HISTOLOGY; LIVER FAILURE; LIVER REGENERATION; LIVER RESECTION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL RATE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; HEPATECTOMY; LIVER FAILURE; LIVER REGENERATION; MALE; MICE; MICE, INBRED ICR; ORGANOPHOSPHORUS COMPOUNDS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40949140195     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2007.11.010     Document Type: Article

References (33)

1. Tuczek H.V., and Rabes H. Verlust der proliferationsfahigkeit der hepatozyten nach subtotaler hepatektomie. Experientia 27 (1971) 526
2. Panis Y., McMullan D.M., and Emond J.C. Progressive necrosis after hepatectomy and the pathological of liver failure after massive resection. Surgery 121 (1997) 142-149
3. Mochida S., Ogata I., Hirata K., Ohta Y., Yamada S., and Fujiwara K. Provocation of massive hepatic necrosis by endotoxin after partial hepatectomy in rats. Gastroenterology 99 (1990) 771-777
4. Cai S.R., Motoyama K., Shen K.J., Kennedy S.C., Flye M.W., and Ponder K.P. Lovastain decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats. J Hepatol 32 (2000) 67-77
5. Nagao M., Isaji S., Iwata M., and Kawarada Y. The remnant liver dysfunction after 84% hepatectomy in dogs. Hepatogastroenterology 47 (2000) 1564-1569
6. Hasegawa S., Kubota T., Fukuyama N., Kurosawa H., Sekido H., Togo S., et al. Apoptosis of hepatocytes is a main cause of inducing lethal hepatic failure after excessive hepatectomy in rats. Transplant Proc 31 (1999) 558-559
7. Taub R., Greenbaum L., and Peng Y. Transcriptional regulatory signals define cytokine-dependent and-independent pathways in liver regeneration. Semin Liver Dis 19 (1999) 117-127
8. Yamada Y., Kirillova I., Peschon J.J., and Fausto N. Initiation of liver growth by tumor necrosis factor; Deficient liver regeneration in mice lacking type 1 tumor necrosis factor receptor. Proc Natl Acad Sci USA 94 (1997) 1441-1446
9. 2-producing enzyme of human neutrophils. J Biol Chem 256 (1981) 2321-2323
10. Weiss S.J. Tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
11. Otani Y., Takeyoshi I., Koibuchi Y., Matsumoto K., Muramoto M., and Morishita Y. The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. J Heart Lung Transplant 19 (2000) 377-383
12. Kobayashi J., Takeyoshi I., Ohwada S., Iwanami K., Matsumoto K., Muramoto M., et al. The effects of FR167653 in extended liver resection with ischemia in dogs. Hepatology 28 (1998) 459-465
13. Higgins G.M., and Anderson R.M. Experimental pathology of the liver. Arch Pathol 12 (1931) 186-202
14. Gaub J., and Iversen J. Rat liver regeneration after 90% partial hepatectomy. Hepatology 4 (1984) 902-904
15. Schossberg H., Zhang Y., Dudus L., and Engerhardt J.F. Expression of c-fos and c-jun during hepatocellular remodeling following ischemia/reperfusion in mouse liver. Hepatology 23 (1996) 1546-1555
16. Kreuzer K.A., Lass U., Bohn A., Landt O., and Schmidt C.A. Light cycler technology for the quantification of bcr/abl fusion transcripts. Cancer Res 59 (1999) 3171-3174
17. Spagnuolo-Weaver M., Fuerst R., Campbell S.T., Meehan B.M., McNeilly F., Adair B., et al. A fluorimeter-based RT-PCR method for the detection and quantitation of porcine cytokine. J Immunol Methods 230 (1999) 19-27
18. Akerman P., Cote P., Yang S.Q., McClain C., Nelson S., Bagby G.J., et al. Antibody to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am J Physiol 263 (1992) G579-G585
19. Shiratori Y., Hongo S., Hikiba Y., Ohmura K., Nagura T., Okano K., et al. Role of macrophages in regeneration of liver. Dig Dis Sci 41 (1996) 1939-1946
20. Diehl A.M., and Rai R.M. Regulation of signal transduction during liver regeneration. FASEB J 10 (1996) 215-227
21. Satoh M., and Yamazaki M. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor-β and interleukin-6. J Cell Physiol 150 (1992) 134-139
22. Koukoulis G., Rayner A., Tan K.C., Williams R., and Portmann B. Immunolocalization of regenerating cells after submassive liver necrosis using PCNA staining. J Pathol 166 (1992) 359-368
23. Kimura T., Sakaida I., Terai S., Matsumura Y., Uchida K., and Okita K. Inhibition of tumor necrosis factor-α production retards liver regeneration after partial hepatectomy in rats. Biochem Biophys Res Com 231 (1997) 557-560
24. Higashitsuji H., Arii S., Furutani M., Mise M., Monden K., Fujita S., et al. Expression of cytokine genes during liver regeneration after partial hepatectomy in rats. J Surg Res 58 (1995) 267-274
25. Schierwagen C., Bylund-Fellenius A.C., and Lundberg C. Improved method for quantification of tissue PMN accumulation measured by myeloperoxidase activity. J Pharmacol Methods 23 (1990) 179-186
26. Fujita J., Marino M.W., Wada H., Jungbluth A.A., Mackrell P.J., Rivadeneira D.E., et al. Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery 129 (2001) 48-54
27. Yachida S., Kokudo Y., Wakabayashi H., Maeba T., Kaneda K., and Maeta H. Morphological and functional alterations to sinusoidal endothelial cells in the early phase of endotoxin-induced liver failure after partial hepatectomy in rats. Virchows Arch 433 (1998) 173-181
28. Ogata K., Jin M.B., Tanigchi M., Suzuki T., Shimamura T., Kitagawa N., et al. Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722. Transplantation 71 (2001) 1040-1046
29. Lentsch A.B., Kato A., Yoshidome H., McMasters K.M., and Edward M.J. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32 (2000) 169-173
30. Jaeschke H., Ho Y.S., Fisher M.A., Lawson J.A., and Farhood A. Glutathione peroxidase-deficient mice are more susceptible to neutrophils-mediated hepatic parenchymal cell injury during endotoxemia: importance of an intracellular oxidant stress. Hepatology 29 (1999) 443-450
31. Fausto N. Liver regeneration: from laboratory to clinic. Liver Transplant 7 (2001) 835-844
32. Luster M.I., Simeonova P.P., Gallucci R., and Matheson J. Tumor necrosis factor alpha and toxicology. Crit Rev Toxicol 29 (1999) 491-511
33. Van Dullemen H.M., van Deventer S.J., Hommes D.W., Bijl H.A., Tytgat G.N., and Woody J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109 (1995) 129-135